Related Experiment Video
Updated: Jan 19, 2026

Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
Published on: January 21, 2019
Thematic Issue: Immuno-Oncology and Immunotherapy
1Sechenov First Moscow State Medical University, Institute of Molecular Medicine, Moscow, 119991, Russia. zamyat@belozersky.msu.ru.
Currently, the use of immunotherapeutic approaches for creating new efficient therapeutic agents for cancer treatment is considered as one of the most promising areas in oncology. Despite significant advances in immuno-oncology during the recent years, some unresolved problems remain. The articles included in this thematic issue highlight the topical aspects of cancer immunotherapy by presenting different viewpoints of scientists, physicians, and drug developers.
Currently, the use of immunotherapeutic approaches for creating new efficient therapeutic agents for cancer treatment is considered as one of the most promising areas in oncology. Despite significant advances in immuno-oncology during the recent years, some unresolved problems remain. The articles included in this thematic issue highlight the topical aspects of cancer immunotherapy by presenting different viewpoints of scientists, physicians, and drug developers.
More Related Videos
Related Concept Videos
10:49Automated Multiplex Immunofluorescence Panel for Immuno-oncology Studies on Formalin-fixed Carcinoma Tissue Specimens
08:17A Human Peripheral Blood Mononuclear Cell (PBMC) Engrafted Humanized Xenograft Model for Translational Immuno-oncology (I-O) Research
Thematic Layering in GIS
06:51Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
Ethical Issues
Ethical Concerns in Healthcare:
Tumor Immunotherapy

